Skip to content

Clinical trials

Phase 2 Hepatitis B trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20072
20102
20141
20161
20184
20191
20203
20215
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated5
Active, not recruiting4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Assembly Biosciences5
Gilead Sciences3
F-star Therapeutics, Inc.2
Sanofi Pasteur, a Sanofi Company2
Aligos Therapeutics1
AusperBio Therapeutics Inc.1
Bristol-Myers Squibb1
Dynavax Technologies Corporation1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B28
Hepatitis B, Chronic15
Hepatitis5
Diphtheria3
Poliomyelitis3
Tetanus3
Haemophilus Infections2
Hepatitis, Chronic2
Whooping Cough2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.